The condemnation came as the House of Lords debated regulations paving the way for a scheme which would require animal lovers on the British mainland to have documentation in order to visit Northern Ireland. Critics view the move as further evidence of Northern Ireland still having to follow EU rules post-Brexit and being treated differently from the rest of the UK – a major source of contention to the unionist community. The paperwork, which will be free to apply for, includes a declaration that the owner will not travel onwards to Ireland or another EU country with their pet or assistance dog. Animals will have to be microchipped and have their own individual pet travel document, which will be valid for its lifetime. Northern Ireland residents returning after a stay in Great Britain with their pet or assistance dog will not need a travel document. The scheme is being introduced under the Windsor Framework, a revised deal for Northern Ireland’s post-Brexit trading arrangements aimed at tackling issues caused by the protocol. Raising her concerns in Parliament, Baroness Hoey, a Northern Irish Brexit supporter and former Labour MP, said: “These regulations are in effect about a new aspect of the Irish Sea border that has not had expression until this point because of the grace periods.” She added: “The experience of visiting Northern Ireland with your pet dog or cat, or even a ferret, will be made to feel like a visit to a foreign country. Lady Hoey went on: “This could spell the end of holiday trips for pet owners from GB to NI and then on to the Republic, when they want to explore both Northern Ireland and the Republic. “If they have a pet passport, they will have renounced their right to go to the Republic. That makes the border more of an obstruction than having border control posts on it, because at least in that eventuality, you could still cross over it.” Rejecting claims it was a result of the UK leaving the EU, she said: “The reality is that this is happening precisely because Northern Ireland has not got Brexit. “As we say repeatedly, it is still subject to EU rules and the EU could change the rules overnight.” Former DUP deputy leader Lord Dodds of Duncairn said: “Every one of the statutory instruments that come forward under the Windsor Framework must be properly debated, because these laws are being brought forward to implement what a foreign jurisdiction has decided should be the law of the United Kingdom. “In the 21st century, we should not accept colonial rule. We abolished it elsewhere. We believe it should not be tolerated for one second. People should have the democratic right to decide their laws for themselves, in their interests.” He added: “The ridiculous part about this debate is that we are having to debate European laws regulating the movement of pet animals owned by British citizens between one part of the United Kingdom and another. That is an outrage.” Lord Dodds went on: “As I said, there will be hundreds, thousands more of these regulations, in all areas, affecting the daily lives of people in Northern Ireland. They all add up to a grievous assault on Northern Ireland’s constitutional position.” But former leader of the Social Democratic and Labour Party (SDLP) Baroness Ritchie of Downpatrick said: “I support the Windsor Framework because it is a necessary legal device to deal with the complexities that were presented to us in Ireland, north and south, on the issue of Brexit. “We need a pragmatic solution rather than choosing to have political contests and duels simply for the sake of them.” Introducing the regulations, environment minister Baroness Hayman of Ulloch said: “This scheme will simplify the requirements associated with moving pet dogs, cats and ferrets from Great Britain to Northern Ireland significantly. “It replaces single-use animal health certificates with a free-of-charge lifelong travel document and removes the need for costly pet health treatments. “Pet owners who travel frequently with their pets, or those who rely on the services of an assistance dog to travel independently, will benefit substantially from this change in approach.” However, she acknowledged the concerns raised by peers and promised to continue engagement with them.A new artificial intelligence tool from the nonprofit Digital Promise and ed-tech company Learning Innovation Catalyst (LINC) applies education research to generate different lesson plans for meeting the unique learning needs of each student. The AI-powered platform, , is informed by the (LVN), a web application that Digital Promise has maintained since 2017. LVN curates research-based strategies for building lesson plans that directly address factors that affect student learning, such as sleep, sense of belonging and speed of processing, among many others. In a webinar this week, Barbara Pape, senior director of the Learner Variability Project at Digital Promise, said such tailored lesson plans take a whole-child approach to teaching and learning. “We define learner variability as the recognition that each student, and also all of us, have a set of strengths and challenges across this whole-child framework that are interconnected and vary according to context,” Pape said in the webinar. “And when you understand learner variability, you see a design challenge, not a student problem, and that’s where we’re trying to move with all of this.” Yourway makes it easier for teachers to design custom instructional approaches that support the whole learner, according to Pape, who joined Dr. Cassondra Corbin-Thaddies, vice president of partner and client engagement at LINC, in the webinar this week. Megan Gross, an inclusive learning expert and former California Teacher of the Year, was part of the panel as well. “We know when student identities are seen and honored and valued in the classroom that students have the ability to cognitively attend and make growth and have an academic mindset, because they feel belonging,” Gross said in the webinar. Demonstrating Yourway, Corbin-Thaddies clicked on “AI Tools” and typed “LVN” in a search bar to surface learner variability options from the platform’s list of other AI-powered tools. Yourway is currently equipped to generate LVN-based lesson plans for students in preschool through 12th grade. Pape said they are working to add LVN models for math and 21st-century skills, such as peer collaboration and critical thinking. To generate an LVN-based lesson plan in Yourway, users must input information about the desired grade level, learning outcomes or topics for the lesson. The webinar offered this example of a learning outcome: “Students will be able to determine the meaning of grade-appropriate academic and domain-specific words or phrases in a text using context.” With this information entered, educators move on to a checklist of literacy skills necessary to achieve the desired learning outcome, such as vocabulary and alphabet knowledge, and select those that are challenges for the student. A second checklist requires the teacher to choose cognition factors the student might struggle with, such as attention or inhibition. From there, the user can click a button to generate the lesson plan or opt to provide more details, such as related documents or any standards to which the lesson should align. Two more optional checklists are available as well: one with background factors that can affect student learning, such as vision and primary language, and another that lists social and emotional learning factors, such as self-regulation and stereotype threat. Generating a lesson plan within seconds, Yourway fleshes out multiple teaching strategies and suggested resources for that particular student and learning outcome based upon inputs from the educator. The lesson plan shown in the webinar, for example, listed role-playing exercises as a teaching strategy that ties into social awareness and relationship skills, stating that the educator should “use scenarios that promote understanding and usage of key vocabulary in social interactions.” Teachers can continue to customize lesson plans by clicking the “Request Changes” button and adding prompts, such as “Give me examples of role-playing exercises that promote understanding and usage of key vocabulary in social interactions.” The platform then generates and adds this information to the lesson plan. “You have to now walk alongside the AI and check its work,” Corbin-Thaddies said in the webinar. “It’s a great starting point. The cognitive load has been lifted, and now we’re ready to get into design mode: What could this look like, what else could we add, how could this be stronger?” Educators can access the basic version of Yourway for free. Those who fill out a Digital Promise on their experience with the tool will receive six months of the professional version for free, Pape said in the webinar.By MARC LEVY HARRISBURG, Pa. (AP) — Democratic Sen. Bob Casey of Pennsylvania conceded his reelection bid to Republican David McCormick on Thursday, as a statewide recount showed no signs of closing the gap and his campaign suffered repeated blows in court in its effort to get potentially favorable ballots counted. Casey’s concession comes more than two weeks after Election Day, as a grindingly slow ballot-counting process became a spectacle of hours-long election board meetings, social media outrage, lawsuits and accusations that some county officials were openly flouting the law. Republicans had been claiming that Democrats were trying to steal McCormick’s seat by counting “illegal votes.” Casey’s campaign had accused of Republicans of trying to block enough votes to prevent him from pulling ahead and winning. In a statement, Casey said he had just called McCormick to congratulate him. “As the first count of ballots is completed, Pennsylvanians can move forward with the knowledge that their voices were heard, whether their vote was the first to be counted or the last,” Casey said. The Associated Press called the race for McCormick on Nov. 7, concluding that not enough ballots remained to be counted in areas Casey was winning for him to take the lead. As of Thursday, McCormick led by about 16,000 votes out of almost 7 million ballots counted. That was well within the 0.5% margin threshold to trigger an automatic statewide recount under Pennsylvania law. But no election official expected a recount to change more than a couple hundred votes or so, and Pennsylvania’s highest court dealt him a blow when it refused entreaties to allow counties to count mail-in ballots that lacked a correct handwritten date on the return envelope. Republicans will have a 53-47 majority next year in the U.S. Senate. Follow Marc Levy at twitter.com/timelywriter
While some of these are well-known and will be no surprise, such as the Grade I-listed Sankey Viaduct reflecting the area's integral part of railway history, and several pub and church buildings across the borough, others are more obscure. The telephone boxes near St Helens town hall, village stocks in Rainford and parish stocks in Newton-le-Willows are also among those listed. What are Listed Buildings? According to Historic England, listing marks and celebrates a building's special architectural and historic interest, and also brings it under the consideration of the planning system, so that it can be protected for future generations. The older a building is, and the fewer the surviving examples of its kind, the more likely it is to be listed. The general principles are that all buildings built before 1700 which survive in anything like their original condition are likely to be listed, as are most buildings built between 1700 and 1850. Particularly careful selection is required for buildings from the period after 1945. Buildings less than 30 years old are not normally considered to be of special architectural or historic interest because they have yet to stand the test of time. What do the Grades mean? Grade I buildings are of exceptional interest, only 2.5% of listed buildings are Grade I. In the borough of St Helens, the Sankey Viaduct in Newton-le-Willows is the only Grade I listed structure. Also known as the 'Nine Arches', this is the world's first major crossing of its kind, was built by George Stephenson between 1828 and 1830, and is the borough's only Grade I-listed structure. Meanwhile, Grade II* buildings are particularly important buildings of more than special interest; 5.8% of listed buildings are Grade II. Grade II buildings are of special interest; 91.7% of all listed buildings are in this class and it is the most likely grade of listing for a home owner. How does the listing process work? There are two main routes to listing. Anyone... Simon MulliganSAN FRANCISCO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- AstraZeneca, the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a series of unsettling reports emanating from China. A widening investigation by China regulators into alleged illegal drug imports, data breaches, and potential health insurance fraud has cast a shadow over the company’s prospects in a critical market, triggering a securities class action lawsuit in the United States. Hagens Berman has opened an investigation into the allegations and urges investors in AstraZeneca American Depositary Shares who suffered substantial losses to submit your losses now. Class Period: Feb. 23, 2022 – Dec. 17, 2024 Lead Plaintiff Deadline: Feb. 21, 2025 Visit: www.hbsslaw.com/investor-fraud/azn Contact the Firm Now: AZN@hbsslaw.com 844-916-0895 Probe Into AstraZeneca’s China Operations The probe conducted by China regulators, which reportedly centers on allegations that AstraZeneca employees improperly imported cancer medications like Enhertu and Imjudo from Hong Kong into mainland China and mishandled patient data, has been compounded by a broader investigation into a large-scale health insurance fraud case. The confluence of these issues has raised serious concerns among investors about the potential impact on the company’s regional sales and overall financial performance. The situation escalated with the arrest of Leon Wang, AstraZeneca’s Executive Vice President International and China President. This development, coupled with internal forecasts predicting a downturn in sales within the Chinese market, has prompted a sharp investor reaction, culminating in the legal action filed in the U.S. District Court for the Central District of California. The AstraZeneca Securities Class Action Suit The lawsuit alleges that AstraZeneca issued “false and misleading statements” and withheld crucial information regarding the company’s exposure to legal and regulatory risks in China. The complaint specifically accuses AstraZeneca of engaging in insurance fraud, facing heightened legal exposure that led to Mr. Wang’s detention, understating the risks associated with its Chinese operations, and failing to disclose the potential for these issues to significantly harm its business and finances in the region. The truth allegedly began to emerge in late October. On October 30, AstraZeneca announced that Mr. Wang was cooperating with a Chinese investigation, offering few details. This initial announcement triggered a 3 percent drop in the company’s share price. The situation worsened on November 5, when Yicai , a Chinese business news outlet, reported that dozens of AstraZeneca China executives were implicated in the investigation, with some potentially facing lengthy prison sentences. The report, citing an industry insider, attributed the alleged compliance issues to “extreme pressure” on sales representatives to meet aggressive sales targets. This news sent AstraZeneca’s stock down another 7 percent. On November 12, AstraZeneca confirmed Mr. Wang’s detention and disclosed that the Chinese investigation encompassed allegations of medical insurance fraud, illegal drug importation, and breaches of personal information. More recently, on December 18, The Financial Times reported that AstraZeneca executives anticipate a decline in Chinese revenue due to the arrests of Mr. Wang and other senior executives. The report quoted an AstraZeneca executive who stated that “doctors are unwilling to interact with our salespeople and prescribe our medicines” following the investigation, precipitating a further nearly 4 percent decline in the company’s share price. Hagens Berman Investigation These events have prompted shareholder rights firm to open an investigation in the allegations. “Should the allegations be confirmed, it suggests AstraZeneca misled investors about the true extent of its exposure in China, a failure with potentially serious consequences,” said Reed Kathrein, an attorney leading the firm's investigation. If you invested in AstraZeneca and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now » If you’d like more information and answers to frequently asked questions about the AstraZeneca investigation, read more » Whistleblowers: Persons with non-public information regarding AstraZeneca should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email AZN@hbsslaw.com . About Hagens Berman Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com . Follow the firm for updates and news at @ClassActionLaw . Contact: Reed Kathrein, 844-916-0895
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (“Rule 5250”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q3 Form 10-Q”) in a timely manner. Under Nasdaq rules, the Company has 60 calendar days from receipt of the 5250 Notice or until January 21, 2025, to submit a plan to regain compliance with the Listing Rule. If Nasdaq accepts the Company’s plan, then Nasdaq may grant an exception of up to 180 calendar days from the due date of the Q3 Form 10-Q, or until May 19, 2025, to regain compliance. In response to the Notice, the Company is working to file the Q3 Form 10-Q as soon as possible in order to regain compliance with the Listing Rule. However, if the Company does not submit the Q3 Form 10-Q by January 21, 2025, the Company will submit a plan by such date to Nasdaq that outlines, as definitively as possible, the steps the Company will take to promptly file the Q3 Form 10-Q. Additionally, on November 25, 2024, the Company received a notice (the “5605 Notice”) from Nasdaq advising the Company that, following the appointment of Brynner Chiam as Acting Principal Executive Officer and Acting Principal Financial Officer of the Company on November 6, 2024, the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Listing Rule 5605 (“Rule 5605”). Nasdaq advised that consistent with Listing Rule 5605(c)(4), Nasdaq will provide the Company with a cure period in order to regain compliance with Rule 5605: (i) until the earlier of the Company’s next annual shareholders’ meeting or November 6, 2025; or (ii) if the next annual shareholders’ meeting is held before May 5, 2025, then the Company must evidence compliance no later than May 5, 2025. The Company intends to appoint an additional independent director to the Board of Directors and the Audit Committee prior to the end of the cure periods. About Titan Pharmaceuticals Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), formerly based in South San Francisco, CA, is a development stage company previously focused on developing proprietary therapeutics utilizing ProNeura® long-term, continuous drug delivery technology. In December 2021, Titan commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Forward-Looking Statements This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect Schmitt's business, including the business of its subsidiary, is included in “Risk Factors” in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission. Media & Investor Contacts Brynner Chiam Acting Principal Executive Officer and Acting Principal Financial Officer (786) 769-7512
Two announce bids to run for Santa Fe mayor in 2025
CLEVLEAND (AP) — Shane Bieber's comeback with Cleveland has double meaning. And deeper meaning. The former Cy Young winner re-signed with the Guardians on Wednesday, a reunion that seemed unlikely when he became a free agent following last season. However, the 29-year-old Bieber decided to stick with the AL Central champions after making just two starts in 2024 before undergoing Tommy John surgery. There were other offers. None of them matched what he already had in Cleveland. “It's the relationships,” Bieber said on a Zoom call. "The development staff. The coaching staff. My teammates. Having continuity and familiarity in those realms I feel like can prove beneficial not only to me but my family and everybody really involved. "That was big for me to feel confident in my rehab where I’m at right now. Nobody knows me as well as Cleveland does and vice versa, so I’m happy to be continuing with them." Bieber agreed last week to a one-year, $14 million contract . The deal includes a $16 million player option for 2026. Not long ago, it seemed as if Bieber, who is 62-32 with a 3.22 ERA in 132 starts over seven seasons for Cleveland, was determined to continue his career elsewhere. He had turned down previous long-term offers in the past from the Guardians, and it was expected he would sign with another contender, likely on the West Coast. But the California native has a special connection with the Guardians, who selected him in the fourth round of the 2016 draft. And while a setback, the injury and surgery helped Bieber realize that he was already in the perfect place. “I had plenty of great meetings and beneficial and progressive meetings with other ball clubs,” he said. "Everybody handled everything first class all the way, and I’ve got great things to say about plenty of other organizations. “Ultimately, Cleveland made the call and I was happy to receive it and come to terms and so I’m happy with where I’m at. My family’s ecstatic. It was very clearly the right decision for not only myself, my family, and we’re excited to continue it.” Bieber, who won the AL Cy Young in the pandemic-shortened 2020 season, threw only 12 innings last season before lingering issues with his elbow forced him to have surgery. He is expected to join Cleveland's rotation at some point in 2025. He's throwing three days a week at 90 feet and encouraged by his progress. As for when he'll take the mound in a game, that's currently unknown. “I’m pushing, pushing, pushing.” he said. “I feel great. I haven’t skipped a beat. When I ask for a (return) date, they don’t even give me a date. So there’s a long way to go.” A two-time All-Star, Bieber burst onto the national stage in 2019 when he was named MVP of the midsummer event in Cleveland. He has the highest strikeout ratio per nine innings (10.2) and third-highest winning percentage (.660) in the franchise's 124-year history. Bieber is one of just three Cleveland pitchers to start five season openers, joining Stan Coveleski (1917-21) and Corey Kluber (2015-19). While Bieber had some elbow issues in the past, he didn't appear to be struggling before being shut down. He struck out 11 in six scoreless innings against Oakland on March 28, and followed that up with six more shutout innings at Seattle on April 2. Days later, and with his season officially over, Bieber became emotional during a news conference at Progressive Field. He knew that in the short-term his life would be different and baseball, as he had always known it, would be on the backburner. Bieber said it took a while before he “digested” his new reality. He coped by immersing himself in his recovery, and Bieber found joy in watching his teammates storm through an unexpected season to a division title. Although it may not have been the same because he wasn't contributing on the field the way he always had, the hardships may have given Bieber something he needed. “It’s provided a lot of perspective,” he said. “It was a hard season this year for me and my family, but it was a great one. We’re expecting a baby and it was a season full of growth and I’m very excited to continue that into 2025.” AP MLB: https://apnews.com/hub/MLBRaiders confirm QB Gardner Minshew out for season, look to Aidan O'ConnellWASHINGTON (AP) — Special counsel Jack Smith moved to abandon two criminal cases against Donald Trump on Monday, acknowledging that Trump’s return to the White House will preclude attempts to federally prosecute him for retaining classified documents or trying to overturn his 2020 election defeat. The decision was inevitable, since longstanding Justice Department policy says sitting presidents cannot face criminal prosecution. Yet it was still a momentous finale to an unprecedented chapter in political and law enforcement history, as federal officials attempted to hold accountable a former president while he was simultaneously running for another term. Trump emerges indisputably victorious, having successfully delayed the investigations through legal maneuvers and then winning re-election despite indictments that described his actions as a threat to the country's constitutional foundations. “I persevered, against all odds, and WON," Trump exulted in a post on Truth Social, his social media website. He also said that “these cases, like all of the other cases I have been forced to go through, are empty and lawless, and should never have been brought.” The outcome makes it clear that, when it comes to a president and criminal accusations, nothing supersedes the voters' own verdict. In court filings, Smith's team emphasized that the move to end their prosecutions was not a reflection of the merit of the cases but a recognition of the legal shield that surrounds any commander in chief. “That prohibition is categorical and does not turn on the gravity of the crimes charged, the strength of the Government’s proof, or the merits of the prosecution, which the Government stands fully behind,” prosecutors said in one of their filings. They wrote that Trump’s return to the White House “sets at odds two fundamental and compelling national interests: on the one hand, the Constitution’s requirement that the President must not be unduly encumbered in fulfilling his weighty responsibilities . . . and on the other hand, the Nation’s commitment to the rule of law.” In this situation, “the Constitution requires that this case be dismissed before the defendant is inaugurated,” they concluded. Smith’s team said it was leaving intact charges against two co-defendants in the classified documents case — Trump valet Walt Nauta and Mar-a-Lago property manager Carlos De Oliveira — because “no principle of temporary immunity applies to them.” Steven Cheung, Trump's incoming White House communications director, said Americans “want an immediate end to the political weaponization of our justice system and we look forward to uniting our country.” Trump has long described the investigations as politically motivated, and he has vowed to fire Smith as soon as he takes office in January. Now he will start his second term free from criminal scrutiny by the government that he will lead. The election case brought last year was once seen as one of the most serious legal threats facing Trump as he tried to reclaim the White House. He was indicted for plotting to overturn his defeat to Joe Biden in 2020, an effort that climaxed with his supporters' violent attack on the U.S. Capitol on Jan. 6, 2021. But the case quickly stalled amid legal fighting over Trump’s sweeping claims of immunity from prosecution for acts he took while in the White House. The U.S. Supreme Court in July ruled for the first time that former presidents have broad immunity from prosecution, and sent the case back to U.S. District Judge Tanya Chutkan to determine which allegations in the indictment, if any, could proceed to trial. The case was just beginning to pick up steam again in the trial court in the weeks leading up to this year’s election. Smith’s team in October filed a lengthy brief laying out new evidence they planned to use against him at trial, accusing him of “resorting to crimes” in an increasingly desperate effort to overturn the will of voters after he lost to Biden. In asking for the election case to be dismissed, prosecutors requested that Chutkan do it “without prejudice,” raising the possibility that they could try to bring charges against Trump again after he leaves office. But such a move may be barred by the statute of limitations, and Trump may also try to pardon himself while in office. The separate case involving classified documents had been widely seen as legally clear cut, especially because the conduct in question occurred after Trump left the White House and lost the powers of the presidency. The indictment included dozens of felony counts accusing him of illegally hoarding classified records from his presidency at his Mar-a-Lago estate in Palm Beach, Florida, and obstructing federal efforts to get them back. He has pleaded not guilty and denied wrongdoing. The case quickly became snarled by delays, with U.S. District Judge Aileen Cannon slow to issue rulings — which favored Trump’s strategy of pushing off deadlines in all his criminal cases — while also entertaining defense motions and arguments that experts said other judges would have dispensed with without hearings. In May, she indefinitely canceled the trial date amid a series of unresolved legal issues before dismissing the case outright two months later. Smith’s team appealed the decision, but now has given up that effort. Trump faced two other state prosecutions while running for president. One them, a New York case involving hush money payments, resulted in a conviction on felony charges of falsifying business records. It was the first time a former president had been found guilty of a crime. The sentencing in that case is on hold as Trump's lawyers try to have the conviction dismissed before he takes office, arguing that letting the verdict stand will interfere with his presidential transition and duties. Manhattan District Attorney Alvin Bragg's office is fighting the dismissal but has indicated that it would be open to delaying sentencing until Trump leaves office. Bragg, a Democrat, has said the solution needs to balance the obligations of the presidency with “the sanctity of the jury verdict." Trump was also indicted in Georgia along with 18 others accused of participating in a sprawling scheme to illegally overturn the 2020 presidential election there. Any trial appears unlikely there while Trump holds office. The prosecution already was on hold after an appeals court agreed to review whether to remove Fulton County District Attorney Fani Willis over her romantic relationship with the special prosecutor she had hired to lead the case. Four defendants have pleaded guilty after reaching deals with prosecutors. Trump and the others have pleaded not guilty. Associated Press writers Colleen Long, Michael Sisak and Lindsay Whitehurst contributed to this story.
Christina Milian defends Blue Ivy Carter after ‘Mufasa’ premiere backlash
TURIN, Italy (Reuters) -Dusan Vlahovic and Weston McKennie scored to lead Juventus to a 2-0 Champions League win over Manchester City on Wednesday, a major blow to the English champions’ hopes of clinching a top-eight spot in the group stage of Europe’s elite competition. City, who lifted the 2023 Champions League trophy, continued a poor run of form which has brought only one victory in their last 10 games across all competitions. “(Confidence) is a big part of it, obviously it’s a mental issue as well. You can see that. You can see that sometimes one action we miss the ball or lose a duel and you can see that we drop immediately,” City midfielder Ilkay Gundogan told Amazon Prime. “It has such a big effect on us right now. At the crucial moment right now we are doing the wrong things.” Vlahovic scored by the narrowest of margins in the 53rd minute when Kenan Yildiz swung the ball in and City keeper Ederson fumbled the Serb’s header from close range and the ball sneaked just across the line, according to the goalline technology. “The whole team played an excellent match, we prepared well and did everything what we had to do,” Vlahovic told Amazon. “The result is amazing and can give us a great boost for the rest of the season.” City picked up the tempo in a desperate attempt to equalise and sent numbers forward, but Juve capitalised to double their lead against the run of play when McKennie hooked Timothy Weah’s cross in with a sumptuous volley in the 75th minute. Pep Guardiola’s team squandered several chances, one of the best falling to Erling Haaland late in first half. Kevin De Bruyne sent a beautiful through ball to the Norwegian who got in behind the defence before trying to chip goalkeeper Michele di Gregorio who threw up his arm to block the shot. Gundogan unleashed a blistering strike from long range that Di Gregorio stretched to just push wide. “We have done it really, really well, we didn’t lose many balls that happened in the past, and we arrived in the positions,” Guardiola said. “But the Italian teams that defend so deep and so compact it is not easy, they are masters of these kinds of situations.” With two games remaining in the group phase, Juventus are 14th in the table while City plummeted to 22nd, three places out of automatic elimination from the competition. Since the start of November, City have conceded more goals (21) across all competitions than any other team in Europe’s big five leagues, the worst spell in Guardiola’s otherwise sparkling managerial career. City, who host Manchester United in the Premier League on Sunday, continue their Champions League campaign at Paris St Germain on Jan. 22. Juventus travel to Brugge on Jan. 21. (Reporting by Lori Ewing,Editing by Toby Davis and Ed Osmond) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );ANOKA, Minn.--(BUSINESS WIRE)--Nov 25, 2024-- Vista Outdoor Inc. (“Vista Outdoor”, the “Company”) (NYSE: VSTO) today announced that its stockholders voted to approve the sale of The Kinetic Group to Czechoslovak Group a.s. (“CSG”) (the “CSG Transaction”) at its special meeting of stockholders held earlier today. Vista Outdoor and CSG have received all regulatory approvals required under the merger agreement for the CSG Transaction and intend to close the CSG Transaction on November 27, 2024. Under the terms of the CSG Transaction, Vista Outdoor stockholders will receive $25.75 in cash and one share of Revelyst common stock for each share of Vista Outdoor common stock they hold. “We are thrilled to have received overwhelming support from our stockholders for the compelling transaction with CSG,” said Michael Callahan, Chairman of the Vista Outdoor Board of Directors. “The CSG transaction maximizes value for our stockholders, while also providing an ideal home for our leading ammunition brands and significant opportunities for our employees.” Based on the vote count from the special meeting of stockholders, approximately 97.89% of votes cast were in favor of the CSG Transaction, representing approximately 82.57% of all outstanding shares. The final voting results will be reported in a Form 8-K filed with the U.S. Securities and Exchange Commission. Following the closing of the CSG Transaction, Revelyst will begin trading on the New York Stock Exchange under the ticker “GEAR”. Subject to the receipt of necessary regulatory approvals and satisfaction of other customary closing conditions, funds managed by Strategic Value Partners, LLC (“SVP”) will subsequently acquire Revelyst in an all-cash transaction based on an enterprise value of $1.125 billion (the “SVP Transaction”), subject to a net cash adjustment. At the closing of the SVP Transaction, Revelyst stockholders will receive an estimated $19.25 in cash per share of Revelyst common stock 1. The SVP Transaction is on track to close by January 2025. No separate approval of the SVP Transaction by Vista Outdoor stockholders is required. Morgan Stanley & Co. LLC is acting as sole financial adviser to Vista Outdoor and Cravath, Swaine & Moore LLP is acting as legal adviser to Vista Outdoor. Moelis & Company LLC is acting as sole financial adviser to the independent directors of Vista Outdoor and Gibson, Dunn & Crutcher LLP is acting as legal adviser to the independent directors of Vista Outdoor. Vista Outdoor (NYSE: VSTO) is the parent company of more than three dozen renowned brands that design, manufacture and market sporting and outdoor products. Brands include Bushnell, CamelBak, Bushnell Golf, Foresight Sports, Fox Racing, Bell Helmets, Camp Chef, Giro, Simms Fishing, QuietKat, Stone Glacier, Federal Ammunition, Remington Ammunition and more. Our reporting segments, Outdoor Products and Sporting Products, provide consumers with a wide range of performance-driven, high-quality and innovative outdoor and sporting products. For news and information, visit our website at Some of the statements made and information contained in this press release, excluding historical information, are “forward-looking statements,” including those that discuss, among other things: Vista Outdoor Inc.’s (“Vista Outdoor”, “we”, “us” or “our”) plans, objectives, expectations, intentions, strategies, goals, outlook or other non-historical matters; projections with respect to future revenues, income, earnings per share or other financial measures for Vista Outdoor; and the assumptions that underlie these matters. The words “believe,” “expect,” “anticipate,” “intend,” “aim,” “should” and similar expressions are intended to identify such forward-looking statements. To the extent that any such information is forward-looking, it is intended to fit within the safe harbor for forward-looking information provided by the Private Securities Litigation Reform Act of 1995. Numerous risks, uncertainties and other factors could cause our actual results to differ materially from the expectations described in such forward-looking statements, including the following: risks related to the previously announced transaction among Vista Outdoor, Revelyst, Inc., CSG Elevate II Inc., CSG Elevate III Inc. and CZECHOSLOVAK GROUP a.s. (the “CSG Transaction”) and risks related to the previously announced transaction among Vista Outdoor, Revelyst, Olibre LLC and Cabin Ridge, Inc. (the “SVP Transaction”) including (i) the possibility that any or all of the various conditions to the consummation of the CSG Transaction or the SVP Transaction may not be satisfied or waived, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals), (ii) the possibility that competing offers or acquisition proposals may be made, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement relating to the CSG Transaction or the SVP Transaction, including in circumstances which would require Vista Outdoor or Revelyst, as applicable, to pay a termination fee, (iv) the effect of the announcement or pendency of the CSG Transaction or the SVP Transaction on our ability to attract, motivate or retain key executives and employees, our ability to maintain relationships with our customers, vendors, service providers and others with whom we do business, or our operating results and business generally, (v) risks related to the CSG Transaction or the SVP Transaction diverting management’s attention from our ongoing business operations, (vi) that the CSG Transaction or the SVP Transaction may not achieve some or all of any anticipated benefits with respect to either business segment and that the CSG Transaction or the SVP Transaction may not be completed in accordance with our expected plans or anticipated timelines, or at all, and (vii) that the consideration paid to Revelyst stockholders in connection with the SVP Transaction cannot be determined until the consummation of the SVP Transaction as it is subject to certain adjustments related to the net cash of Revelyst as of the closing of the SVP Transaction and the management team’s current estimate of the consideration may be higher or lower than the actual consideration paid to Revelyst stockholders in connection with the SVP Transaction due to the actual cash flows prior to the closing of the SVP Transaction or other factors; impacts from the COVID-19 pandemic on our operations, the operations of our customers and suppliers and general economic conditions; supplier capacity constraints, production or shipping disruptions or quality or price issues affecting our operating costs; the supply, availability and costs of raw materials and components; increases in commodity, energy, and production costs; seasonality and weather conditions; our ability to complete acquisitions, realize expected benefits from acquisitions and integrate acquired businesses; reductions in or unexpected changes in or our inability to accurately forecast demand for ammunition, accessories, or other outdoor sports and recreation products; disruption in the service or significant increase in the cost of our primary delivery and shipping services for our products and components or a significant disruption at shipping ports; risks associated with diversification into new international and commercial markets, including regulatory compliance; our ability to take advantage of growth opportunities in international and commercial markets; our ability to obtain and maintain licenses to third-party technology; our ability to attract and retain key personnel; disruptions caused by catastrophic events; risks associated with our sales to significant retail customers, including unexpected cancellations, delays, and other changes to purchase orders; our competitive environment; our ability to adapt our products to changes in technology, the marketplace and customer preferences, including our ability to respond to shifting preferences of the end consumer from brick and mortar retail to online retail; our ability to maintain and enhance brand recognition and reputation; our association with the firearms industry, others’ use of social media to disseminate negative commentary about us, our products, and boycotts; the outcome of contingencies, including with respect to litigation and other proceedings relating to intellectual property, product liability, warranty liability, personal injury, and environmental remediation; our ability to comply with extensive federal, state and international laws, rules and regulations; changes in laws, rules and regulations relating to our business, such as federal and state ammunition regulations; risks associated with cybersecurity and other industrial and physical security threats; interest rate risk; changes in the current tariff structures; changes in tax rules or pronouncements; capital market volatility and the availability of financing; our debt covenants may limit our ability to complete acquisitions, incur debt, make investments, sell assets, merge or complete other significant transactions; foreign currency exchange rates and fluctuations in those rates; general economic and business conditions in the United States and our markets outside the United States, including as a result of the war in Ukraine and the imposition of sanctions on Russia, the conflict in the Gaza strip, the COVID-19 pandemic or another pandemic, conditions affecting employment levels, consumer confidence and spending, conditions in the retail environment, and other economic conditions affecting demand for our products and the financial health of our customers. You are cautioned not to place undue reliance on any forward-looking statements we make, which are based only on information currently available to us and speak only as of the date hereof. A more detailed description of risk factors that may affect our operating results can be found in Part 1, Item 1A, Risk Factors, of our Annual Report on Form 10-K for fiscal year 2024, and in the filings we make with the SEC from time to time. We undertake no obligation to update any forward-looking statements, except as otherwise required by law. 1 Based on management estimates, including an assumption the SVP Transaction closes on December 31, 2024. View source version on : CONTACT: Investor: Tyler Lindwall Phone: 612-704-0147 Email:investor.relations@vistaoutdoor.comMedia: Eric Smith Phone: 720-772-0877 Email:media.relations@vistaoutdoor.com KEYWORD: MINNESOTA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: RETAIL OTHER CONSUMER CONSUMER OTHER RETAIL MANUFACTURING OTHER MANUFACTURING SOURCE: Vista Outdoor Inc. Copyright Business Wire 2024. PUB: 11/25/2024 04:01 PM/DISC: 11/25/2024 04:01 PM
UConn vs. Memphis score: Tigers shock No. 2 Huskies in overtime thriller to open Maui Invitational
None
With Gaetz out as attorney general pick, Trump’s right flank looks for a new ally at FBI
Google on Wednesday unleashed another wave of artificial intelligence designed to tackle more of the work and thinking done by humans as it tries to stay on the technology's cutting edge while also trying to fend off regulatory threats to its empire. The next generation of Google's AI is being packaged under the Gemini umbrella, which was unveiled a year ago. Google is framing its release of Gemini 2.0 as a springboard for AI agents built to interpret images shown through a smartphone, perform a variety of tedious chores, remember the conversations consumers have with people, help video game players plot strategy and even tackle the task of doing online searches. In a blog post, Google CEO Sundar Pichai predicted the technology contained in Gemini 2.0 will “understand more about the world around you, think multiple steps ahead and take action on your behalf, with your supervision.” It's a similar goal being pursued by hard-charging rivals such as OpenAI, with its chatGPT technology, and industry powerhouse such as Microsoft with a variety of similar tools on its Windows software. A lot of Google's latest AI technology will initially be confined to test groups and subscribers who pay $20 per month for Gemini Advanced, but some features will be made available through its search engine and mobile apps. Google is planning wider releases next year that will include the technology popping up in its smorgasbord of free products, including its Chrome browser, digital maps and YouTube. Besides trying to outshine OpenAI and other ambitious startups, Google is also trying to stay a step ahead of Apple as that trendsetting company begins to blend AI into its latest iPhones and other devices. After releasing a software update enabling the first bundle of the iPhone's “Apple Intelligence” features that spruced up the device's Siri assistant, another batch of the AI technology is scheduled to come out before the end of this year. Google is pushing forward with its latest AI advances even as the U.S. Justice Department is trying to break up the Mountain View, California, company to prevent further abusive practices by its dominant search engine, which was declared an illegal monopoly by a federal judge earlier this year as part of a landmark antitrust case. Among other things, Gemini 2.0 is supposed to improve the AI overviews that Google began highlighting in its search results over its traditional listing of the most pertinent links to websites earlier this year in response to AI-powered “answer engines” such as Perplexity. After the AI overviews initially produced some goofy suggestions, including putting glue on pizza, Google refined the technology to minimize such missteps. Now, the company executives are promising things are going to get even better with Gemini 2.0, which Pichai said will be able to engage in more human-like reasoning while solving more advanced math problems and even churn out some computer code. The improvements to AI Overviews will initially only appear to a test audience before a wider release next year. The technological upgrade is also supposed to infuse a still-experimental universal AI agent dubbed “Project Astra,” with even more smarts and versatility, enabling people to have more meaningful and helpful conversations with the technology. In a show of confidence, Google said it will expand the number of people testing Project Astra without providing any specifics of the group's size. As part of Gemini 2.0, Google is also going to begin testing an extension to Chrome called “Project Mariner,” which can be turned on to do online searches and sift through the results so people don't won't have to bother. If the U.S. Department of Justice gets its way, Google will be forced to sell or spin off Chrome as part of its punishment for deploying its search engine in ways that stifled competition and potential innovation. Google has ridiculed the Justice Department's proposal as “overly broad” and vowed to resist any attempt to break up the company during federal court hearings scheduled to begin in Washington D.C. next spring. Even if those proceedings culminate in a court order mandating a breakup, Google could still appeal in a process that could take years to resolve while it continues its AI expansion. “I can’t wait to see what this next era brings,” Pichai wrote in his blog post, signaling the company doesn't believe it will be deterred by regulators.
Louisiana judge halts state police plans to clear New Orleans homeless camps before ThanksgivingSolid Power: Heating Up, But Don't Get BurnedItaly will not send troops to Ukraine: Foreign minister
5 Notable Ways Aviation Has Changed Since The PandemicMid-American Conference football goes all in on November weeknights for the TV viewers
ultra mega song
0 degrees switch
0ega